TL;DR
This paper reports the first known cases of linezolid-resistant Staphylococcus (MRCoNS) and Enterococcus faecium in China, identified in intensive care units. The study highlights clonal spread and identifies specific genetic mutations (G2576T, C2104T) and the cfr gene as key mechanisms of resistance, underscoring the need for vigilant monitoring of this emerging threat.
What Problem Does This Paper Address?
Linezolid is a crucial antibiotic for treating infections caused by Gram-positive bacteria, including difficult-to-treat strains like MRSA and VRE. However, the emergence of linezolid resistance poses a significant threat to its clinical utility. While linezolid resistance has been documented in other parts of the world, there was a notable absence of reported cases in China. This paper addresses the critical need to identify and characterize the first clinical isolates of linezolid-resistant MRCoNS and E. faecium in China, to understand the genetic basis of this resistance, and to assess its potential for clonal dissemination within healthcare settings.
Methods
The researchers employed a combination of standard and molecular techniques:
- Bacterial Identification and Susceptibility Testing: Standard methods were used to identify bacterial species and determine their susceptibility to various antibiotics, including linezolid, using Etest and disc diffusion methods.
- Molecular Typing (PFGE): Pulsed-field gel electrophoresis (PFGE) was used to analyze the genomic DNA of the isolates. This technique separates large DNA fragments based on size, allowing researchers to assess the genetic relatedness of different bacterial strains and identify clonal outbreaks.
- Genetic Analysis (PCR and Sequencing): Polymerase Chain Reaction (PCR) was used to amplify specific regions of the bacterial genome, namely domain V of the 23S rRNA gene and the cfr gene, which are known to be involved in linezolid resistance. The amplified DNA fragments were then sequenced to identify specific mutations.
- Southern Blot Analysis: This technique was used to investigate the location of the cfr gene, specifically to determine if it was located on plasmids.
Datasets
Not discussed in the paper. The study focused on clinical isolates recovered from patients in a Chinese hospital.
Key Insights and Ideas
- First Report in China: This study marks the first documented emergence of linezolid-resistant MRCoNS and E. faecium in China, highlighting a new geographical frontier for this resistance.
- Clonal Dissemination: PFGE analysis revealed that many of the resistant MRCoNS isolates belonged to clonal strains, suggesting that resistant bacteria were spreading within the hospital, likely through patient-to-patient transmission.
- Dual Resistance Mechanisms: The study identified two primary mechanisms of linezolid resistance:
- Point Mutations: A common mutation (G2576T) in the 23S rRNA gene was observed, along with a novel mutation (C2104T) in S. capitis isolates. These mutations are believed to interfere with linezolid binding.
- cfr Gene: The presence of the cfr gene, which encodes an rRNA methyltransferase, was a significant finding. This gene confers resistance to a broad range of antibiotics, including linezolid.
- Potential for Underestimation: The finding of a E. faecium isolate with only one or two copies of the mutated 23S rRNA gene suggests that some resistant strains might be missed by standard susceptibility testing, emphasizing the need for careful monitoring.
- Broader Resistance Profile: The cfr gene was found in most staphylococci, and these isolates also showed resistance to other antibiotics, indicating a potential for multidrug resistance.
Key Results
- Seventeen linezolid-resistant MRCoNS (ten S. capitis, four S. cohnii, two S. haemolyticus, one S. sciuri) and one E. faecium isolate were recovered from intensive care units.
- Linezolid MICs for most MRCoNS were very high (>256 µg ml⁻¹), with some exceptions (6 µg ml⁻¹). The E. faecium isolate had an MIC of 8 µg ml⁻¹.
- PFGE showed that four S. cohnii isolates were from a clonal strain, and nine S. capitis isolates were indistinguishable (clone A1).
- The G2576T mutation in the 23S rRNA gene was found in E. faecium and S. sciuri.
- A novel C2104T mutation, in addition to G2576T, was identified in nine S. capitis clone A1 isolates.
- The cfr gene was detected in all staphylococci except S. sciuri.
- The study identified specific amino acid mutations in ribosomal proteins L3 and L4 in S. cohnii that were not previously reported.
Limitations and Future Work
- Limited Scope: The study focused on a single hospital, and the findings may not be representative of the entire country.
- Plasmid Location of cfr: While the cfr gene was detected, its precise location (e.g., on a plasmid) could not be definitively confirmed by Southern blot, suggesting it might be on a low-copy-number plasmid or integrated into the chromosome. Further investigation into the mobile genetic elements carrying cfr is warranted.
- Clinical Impact: While the paper reports on clinical isolates and patient outcomes (including deaths), a more in-depth analysis of the direct clinical impact of these resistant strains and the effectiveness of alternative treatments would be valuable.
- Monitoring and Surveillance: The authors emphasize the need for continued surveillance and careful monitoring of linezolid resistance, especially in patients undergoing prolonged linezolid therapy, to prevent further dissemination. Future work should focus on developing rapid diagnostic methods for detecting these resistance mechanisms.
Summary updated